Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cirrhosis With Hepatocellular Carcinoma”

124 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 124 results

Not applicableUnknownNCT04076631
What this trial is testing

Surgical Stages of Liver Cirrhosis In Patients With Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaLiver Cirrhosis
Chen Xiaoping 1,000
Not applicableUnknownNCT05963776
What this trial is testing

Pulmonary Function Tests Study in Cirrhotic Patients With and Without Hepatocellular Carcinoma

Who this might be right for
Pulmonary Complications of Liver Cirrhosis and HCC
Sohag University 40
Not applicableUnknownNCT00160940
What this trial is testing

Differential Gene Expression of Liver Tissue and Blood From Individuals With Chronic Viral Hepatitis

Who this might be right for
Hepatitis CHepatitis BAutoimmune Hepatitis+2 more
University Health Network, Toronto 200
Early research (Phase 1)Study completedNCT02151864
What this trial is testing

LDE225 in Patients With Advanced or Metastatic Hepatocellular Carcinoma and Child-Pugh A/B7 Cirrhosis

Who this might be right for
Hepatocellular CarcinomaCirrhosis
Jason K. Sicklick, M.D. 9
Not applicableActive Not RecruitingNCT05756699
What this trial is testing

Evaluation of Proteome Multimarker Panel With Multiple Reaction Monitoring as a Surveillance for Hepatocellular Carcinoma

Who this might be right for
Liver Cirrhosis
Seoul National University Hospital 200
Testing effectiveness (Phase 2)Ended earlyNCT04497038
What this trial is testing

Cabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First-Line Therapy

Who this might be right for
Advanced Adult Hepatocellular Carcinoma
University of Michigan Rogel Cancer Center 3
Large-scale testing (Phase 3)Not Yet RecruitingNCT07529262
What this trial is testing

Can Aspirin Reduce the Risk of HCC in Cirrhosis: The AspiRe HCC Trial

Who this might be right for
Liver Cirrhosis
Curtin University 890
Not applicableUnknownNCT02321579
What this trial is testing

Vitamin B-6 and Glutathione on Inflammation, Homocysteine, Oxidative Stress and Antioxidant Capacities

Who this might be right for
Liver CirrhosisLiver Cancer
Taichung Veterans General Hospital 25
Not applicableNot Yet RecruitingNCT07189624
What this trial is testing

Effect of Acute Endurance Exercise on the Production of FGF21 and Follistatin in Patients With Hepatocellular Carcinoma

Who this might be right for
Cirrhosis With Hepatocellular Carcinoma
University Hospital, Clermont-Ferrand 12
Not applicableStudy completedNCT01390194
What this trial is testing

Rapid 10-Minute Liver MRI Protocol in Patients With Suspected Hepatocellular Carcinoma

Who this might be right for
Underlying Liver DiseaseHepatitisFibrosis of Liver+2 more
University of Nebraska 25
Not applicableNot Yet RecruitingNCT07667608
What this trial is testing

Ultrasound Assessment of Diaphragmatic Structure and Function in Patients With Liver Cirrhosis: A Point-of-Care Tool for Predicting Complications and Sarcopenia in Limited Resource Settings

Who this might be right for
Cirrhosis of the LiverAscitesPleural Effusion Disorder+3 more
Assiut University 120
Testing effectiveness (Phase 2)Study completedNCT01357486
What this trial is testing

Palliative Treatment of Hepatocellular Carcinoma in Patient With CHILD B Cirrhosis

Who this might be right for
Hepatocellular CarcinomaCHILD B
University Hospital, Bordeaux 160
Not applicableEnrolling By InvitationNCT06624189
What this trial is testing

Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis

Who this might be right for
Hepatocellular CarcinomaCirrhosis
NYU Langone Health 1,300
Large-scale testing (Phase 3)Study completedNCT00190385
What this trial is testing

Screening of Hepatocellular Carcinoma in Patients With Compensated Cirrhosis

Who this might be right for
Compensated Cirrhosis
Assistance Publique - Hôpitaux de Paris 1,200
Not applicableUnknownNCT04443049
What this trial is testing

To Study the Effects of Addition of Mebendazole to Lenvatinib in Cirrhotics With Advanced Hepatocellular Carcinoma.

Who this might be right for
Hepatocellular CarcinomaLiver Cirrhosis
Institute of Liver and Biliary Sciences, India 170
Large-scale testing (Phase 3)Ended earlyNCT01342705
What this trial is testing

Phlebotomy and Risk of Hepatocellular Carcinoma in Patients With Compensated Alcoholic Cirrhosis

Who this might be right for
Alcoholic CirrhosisIron Overload
Assistance Publique - Hôpitaux de Paris 17
Not applicableLooking for participantsNCT06778317
What this trial is testing

MSEPT9 Biomarker for Predicting Hepatocellular Carcinoma Occurrence in Patients With Cirrhosis

Who this might be right for
Hepatocellular Carcinoma (HCC)CirrhosisRisk Prediction for Liver Cancer+1 more
Central Hospital, Nancy, France 400
Not applicableNot Yet RecruitingNCT07481032
What this trial is testing

Effect of Fufang Biejiaruangan Combined With Antiviral Therapy on the Incidence of Hepatocellular Carcinoma in Patients With Hepatitis B-related Cirrhosis: A Multicenter, Randomized, Placebo-controlled Study

Who this might be right for
Cirrhosis, LiverHepatocellular Carcinoma (HCC)HEPATITIS B CHRONIC
Nanfang Hospital, Southern Medical University 1,034
Not applicableUnknownNCT04414956
What this trial is testing

Combining Biomarkers (AFP, AFP-L3, and PIVKA-II) and Image Tools for Early Detection of Hepatocellular Carcinoma

Who this might be right for
Liver CirrhosisHepatocellular CarcinomaSurveillance
Korea University 1,418
Early research (Phase 1)Study completedNCT02143401
What this trial is testing

Navitoclax and Sorafenib Tosylate in Treating Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
CirrhosisHepatitis B InfectionHepatitis C Infection+6 more
National Cancer Institute (NCI) 29
Next Page